{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:00:30Z","timestamp":1790172030895,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"40","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,10,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Anterior Gradient 2 (AGR2) is an endoplasmic reticulum (ER)-resident protein that belongs to the protein disulphide isomerase (PDI) family, and whose expression and secretion are induced by stress. Extracellular (secreted) AGR2 has been proposed as a marker of ER stress\u2013related proteostasis alterations. Cancer cells frequently overexpress intracellular AGR2 (iAGR2) and secrete extracellular AGR2 (eAGR2). These features are associated with tumour progression and may serve as potential biomarkers in epithelial ovarian cancer (EOC). To investigate the roles of both iAGR2 and eAGR2 in EOC, we first generated EOC cells overexpressing iAGR2 and secreting eAGR2. Antibodies blocking eAGR2 reduced the proliferation and migration of these overexpressing cells. Concurrently, supplementation of parental cells with recombinant eAGR2 partially rescued these properties, further supporting a functional extracellular role for AGR2 in EOC. Quantitative proteomics, complemented by analysis of the TCGA database, revealed that eAGR2 modulated the expression of proteins involved in autophagy. This suggests that eAGR2-induced signalling may enhance catabolic activity under stress conditions, thereby increasing nutrient availability and, in turn, facilitating protein synthesis. This was reflected in the increased translational activity observed in AGR2-overexpressing and eAGR2-stimulated cells. Our results highlight two distinct, compartmentalised roles for AGR2. Specifically, iAGR2 acts as an ER-resident PDI, enhancing protein folding and ER quality control. In a complementary manner, eAGR2 functions as a metabolic regulator that may relieve constraints on tumour cell aggressiveness by maintaining autophagic flux and promoting protein synthesis. Overall, these findings support a dual-compartment model in which iAGR2 couples ER proteostasis with the metabolic and translational stimulation mediated by eAGR2.<\/jats:p>","DOI":"10.1038\/s41388-026-03938-y","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:48:54Z","timestamp":1786376934000},"page":"4215-4235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complementary intra- and extracellular AGR2 activities support epithelial ovarian cancer cell aggressiveness"],"prefix":"10.1038","volume":"45","author":[{"given":"Marianne","family":"Guilbard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00efd","family":"Taouji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Pineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romane","family":"Florent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6935-100X","authenticated-orcid":false,"given":"Louis-Bastien","family":"Weiswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Hartog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coriolan","family":"Lebreton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alix","family":"Coulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Babin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Chaveroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Beq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5855-4522","authenticated-orcid":false,"given":"Eric","family":"Chevet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Fessart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4600-7633","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Delom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"3938_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.61","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016;2:16061. https:\/\/doi.org\/10.1038\/nrdp.2016.61.","journal-title":"Nat Rev Dis Primers"},{"key":"3938_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1634\/theoncologist.7-suppl_5-20","volume":"7","author":"DK Armstrong","year":"2002","unstructured":"Armstrong DK. Relapsed ovarian cancer: challenges and management strategies for a chronic disease. The Oncologist. 2002;7:20\u20138. https:\/\/doi.org\/10.1634\/theoncologist.7-suppl_5-20.","journal-title":"The Oncologist"},{"key":"3938_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","unstructured":"Cancer Genome Atlas Research NetworkIntegrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609\u201315. https:\/\/doi.org\/10.1038\/nature10166.","journal-title":"Nature"},{"key":"3938_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"key":"3938_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ccell.2020.01.011","volume":"37","author":"DJ McGrail","year":"2020","unstructured":"McGrail DJ, Garnett J, Yin J, Dai H, Shih DJH, Lam TNA, et al. Proteome instability is a therapeutic vulnerability in mismatch repair-deficient cancer. Cancer Cell. 2020;37:371\u2013386.e12. https:\/\/doi.org\/10.1016\/j.ccell.2020.01.011.","journal-title":"Cancer Cell"},{"key":"3938_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59116-x","volume":"10","author":"S Samanta","year":"2020","unstructured":"Samanta S, Tamura S, Dubeau L, Mhawech-Fauceglia P, Miyagi Y, Kato H, et al. Clinicopathological significance of endoplasmic reticulum stress proteins in ovarian carcinoma. Sci Rep. 2020;10:2160. https:\/\/doi.org\/10.1038\/s41598-020-59116-x.","journal-title":"Sci Rep"},{"key":"3938_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1479-7364-6-6","volume":"6","author":"JJ Galligan","year":"2012","unstructured":"Galligan JJ, Petersen DR. The human protein disulfide isomerase gene family. Hum Genomics. 2012;6:6. https:\/\/doi.org\/10.1186\/1479-7364-6-6.","journal-title":"Hum Genomics"},{"key":"3938_CR8","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2024.0561","author":"AS Pierre","year":"2024","unstructured":"Pierre AS, Gavriel N, Guilbard M, Ogier-Denis E, Chevet E, Delom F, et al. Modulation of protein disulfide isomerase functions by localization: the example of the anterior gradient family. Antioxid Redox Signal. 2024. https:\/\/doi.org\/10.1089\/ars.2024.0561.","journal-title":"Antioxid Redox Signal"},{"key":"3938_CR9","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1002\/cam4.3836","volume":"10","author":"LE Powell","year":"2021","unstructured":"Powell LE, Foster PA. Protein disulphide isomerase inhibition as a potential cancer therapeutic strategy. Cancer Med. 2021;10:2812\u201325. https:\/\/doi.org\/10.1002\/cam4.3836.","journal-title":"Cancer Med"},{"key":"3938_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.5483\/bmbrep.2017.50.8.107","volume":"50","author":"E Lee","year":"2017","unstructured":"Lee E, Lee DH. Emerging roles of protein disulfide isomerase in cancer. BMB Rep. 2017;50:401\u201310. https:\/\/doi.org\/10.5483\/bmbrep.2017.50.8.107.","journal-title":"BMB Rep"},{"key":"3938_CR11","doi-asserted-by":"publisher","first-page":"103543","DOI":"10.18632\/oncotarget.21569","volume":"8","author":"S Samanta","year":"2017","unstructured":"Samanta S, Tamura S, Dubeau L, Mhawech-Fauceglia P, Miyagi Y, Kato H, et al. Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancer. Oncotarget. 2017;8:103543\u201356. https:\/\/doi.org\/10.18632\/oncotarget.21569.","journal-title":"Oncotarget"},{"key":"3938_CR12","doi-asserted-by":"publisher","first-page":"44855","DOI":"10.1074\/jbc.M111.275529","volume":"286","author":"A Higa","year":"2011","unstructured":"Higa A, Mulot A, Delom F, Bouchecareilh M, Nguy\u00ean DT, Boismenu D, et al. Role of pro-oncogenic protein disulfide isomerase (PDI) family member anterior gradient 2 (AGR2) in the control of endoplasmic reticulum homeostasis. J Biol Chem. 2011;286:44855\u201368. https:\/\/doi.org\/10.1074\/jbc.M111.275529.","journal-title":"J Biol Chem"},{"key":"3938_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ydbio.2009.12.008","volume":"338","author":"F Zhao","year":"2010","unstructured":"Zhao F, Edwards R, Dizon D, Afrasiabi K, Mastroianni JR, Geyfman M, et al. Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2-\/- mice. Dev Biol. 2010;338:270\u20139. https:\/\/doi.org\/10.1016\/j.ydbio.2009.12.008.","journal-title":"Dev Biol"},{"key":"3938_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1158\/2159-8290.CD-14-1490","volume":"5","author":"E Chevet","year":"2015","unstructured":"Chevet E, Hetz C, Samali A. Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis. Cancer Discov. 2015;5:586\u201397. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-1490.","journal-title":"Cancer Discov"},{"key":"3938_CR15","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.cellsig.2012.03.011","volume":"24","author":"A Higa","year":"2012","unstructured":"Higa A, Chevet E. Redox signaling loops in the unfolded protein response. Cell Signal. 2012;24:1548\u201355. https:\/\/doi.org\/10.1016\/j.cellsig.2012.03.011.","journal-title":"Cell Signal"},{"key":"3938_CR16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1177\/2472555217701685","volume":"22","author":"D Doultsinos","year":"2017","unstructured":"Doultsinos D, Avril T, Lhomond S, Dejeans N, Gu\u00e9dat P, Chevet E. Control of the Unfolded Protein Response in Health and Disease. SLAS Discov Adv Life Sci R D. 2017;22:787\u2013800. https:\/\/doi.org\/10.1177\/2472555217701685.","journal-title":"SLAS Discov Adv Life Sci R D"},{"key":"3938_CR17","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201810120","volume":"11","author":"M Maurel","year":"2019","unstructured":"Maurel M, Obacz J, Avril T, Ding YP, Papadodima O, Treton X, et al. Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammation. EMBO Mol Med. 2019;11:e10120. https:\/\/doi.org\/10.15252\/emmm.201810120.","journal-title":"EMBO Mol Med"},{"key":"3938_CR18","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.13887","volume":"5","author":"D Fessart","year":"2016","unstructured":"Fessart D, Domblides C, Avril T, Eriksson LA, Begueret H, Pineau R, et al. Secretion of protein disulphide isomerase AGR2 confers tumorigenic properties. eLife. 2016;5:e13887. https:\/\/doi.org\/10.7554\/eLife.13887.","journal-title":"eLife"},{"key":"3938_CR19","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1038\/onc.2012.346","volume":"32","author":"E Chevet","year":"2013","unstructured":"Chevet E, Fessart D, Delom F, Mulot A, Vojtesek B, Hrstka R, et al. Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development. Oncogene. 2013;32:2499\u2013509. https:\/\/doi.org\/10.1038\/onc.2012.346.","journal-title":"Oncogene"},{"key":"3938_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bulcan.2021.11.004","volume":"109","author":"F Delom","year":"2022","unstructured":"Delom F, Le Morvan V, Robert J, Fessart D. Normal organoids and their applications in cancer research. Bull Cancer (Paris). 2022;109:58\u201364. https:\/\/doi.org\/10.1016\/j.bulcan.2021.11.004.","journal-title":"Bull Cancer (Paris)"},{"key":"3938_CR21","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1042\/CS20090537","volume":"118","author":"TA Edgell","year":"2010","unstructured":"Edgell TA, Barraclough DL, Rajic A, Dhulia J, Lewis KJ, Armes JE, et al. Increased plasma concentrations of anterior gradient 2 protein are positively associated with ovarian cancer. Clin Sci Lond Engl 1979. 2010;118:717\u201325. https:\/\/doi.org\/10.1042\/CS20090537.","journal-title":"Clin Sci Lond Engl 1979"},{"key":"3938_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2217\/bmm-2023-0178","volume":"17","author":"T Yan","year":"2023","unstructured":"Yan T, Wang H, Ma X, Cao J, Tong Y, Guo L, et al. Clinical value of serum and tissue AGR2 for diagnosis and prognosis in epithelial ovarian cancer. Biomark Med. 2023;17:325\u201336. https:\/\/doi.org\/10.2217\/bmm-2023-0178.","journal-title":"Biomark Med"},{"key":"3938_CR23","doi-asserted-by":"publisher","first-page":"271.","DOI":"10.1186\/s13046-021-02060-z","volume":"40","author":"D Fessart","year":"2021","unstructured":"Fessart D, Robert J, Hartog C, Chevet E, Delom F, Babin G. The Anterior GRadient (AGR) family proteins in epithelial ovarian cancer. J Exp Clin Cancer Res CR. 2021;40:271. https:\/\/doi.org\/10.1186\/s13046-021-02060-z.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"3938_CR24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41416-019-0718-9","volume":"122","author":"HJ Whitwell","year":"2020","unstructured":"Whitwell HJ, Worthington J, Blyuss O, Gentry-Maharaj A, Ryan A, Gunu R, et al. Improved early detection of ovarian cancer using longitudinal multimarker models. Br J Cancer. 2020;122:847\u201356. https:\/\/doi.org\/10.1038\/s41416-019-0718-9.","journal-title":"Br J Cancer"},{"key":"3938_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1658-2","volume":"15","author":"M Alavi","year":"2015","unstructured":"Alavi M, Mah V, Maresh EL, Bagryanova L, Horvath S, Chia D, et al. High expression of AGR2 in lung cancer is predictive of poor survival. BMC Cancer. 2015;15:655. https:\/\/doi.org\/10.1186\/s12885-015-1658-2.","journal-title":"BMC Cancer"},{"key":"3938_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118920","volume":"1868","author":"D Fessart","year":"2021","unstructured":"Fessart D, de Barbeyrac C, Boutin I, Grenier T, Richard E, Begueret H, et al. Extracellular AGR2 triggers lung tumour cell proliferation through repression of p21CIP1. Biochim Biophys Acta Mol Cell Res. 2021;1868:118920. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118920.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3938_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3858\/emm.2011.43.2.011","volume":"43","author":"K Park","year":"2011","unstructured":"Park K, Chung YJ, So H, Kim K, Park J, Oh M, et al. AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp Mol Med. 2011;43:91\u2013100. https:\/\/doi.org\/10.3858\/emm.2011.43.2.011.","journal-title":"Exp Mol Med"},{"key":"3938_CR28","doi-asserted-by":"publisher","first-page":"7811","DOI":"10.1158\/0008-5472.CAN-08-1320","volume":"68","author":"V Ramachandran","year":"2008","unstructured":"Ramachandran V, Arumugam T, Wang H, Logsdon CD. Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res. 2008;68:7811\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1320.","journal-title":"Cancer Res"},{"key":"3938_CR29","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1158\/1535-7163.MCT-14-0470","volume":"14","author":"T Arumugam","year":"2015","unstructured":"Arumugam T, Deng D, Bover L, Wang H, Logsdon CD, Ramachandran V. New blocking antibodies against Novel AGR2-C4.4A pathway reduce growth and metastasis of pancreatic tumors and increase survival in mice. Mol Cancer Ther. 2015;14:941\u201351. https:\/\/doi.org\/10.1158\/1535-7163.MCT-14-0470.","journal-title":"Mol Cancer Ther"},{"key":"3938_CR30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.yexcr.2018.02.004","volume":"364","author":"S Tian","year":"2018","unstructured":"Tian S, Hu J, Tao K, Wang J, Chu Y, Li J, et al. Secreted AGR2 promotes invasion of colorectal cancer cells via Wnt11-mediated non-canonical Wnt signaling. Exp Cell Res. 2018;364:198\u2013207. https:\/\/doi.org\/10.1016\/j.yexcr.2018.02.004.","journal-title":"Exp Cell Res"},{"key":"3938_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07743-y","volume":"21","author":"X Hong","year":"2021","unstructured":"Hong X, Li ZX, Hou J, Zhang HY, Zhang CY, Zhang J, et al. Effects of ER-resident and secreted AGR2 on cell proliferation, migration, invasion, and survival in PANC-1 pancreatic cancer cells. BMC Cancer. 2021;21:33. https:\/\/doi.org\/10.1186\/s12885-020-07743-y.","journal-title":"BMC Cancer"},{"key":"3938_CR32","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s13046-025-03537-x","volume":"44","author":"L Thorel","year":"2025","unstructured":"Thorel L, Dolivet E, Morice PM, Florent R, Divoux J, Perr\u00e9ard M, et al. Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical response. J Exp Clin Cancer Res CR. 2025;44:282 https:\/\/doi.org\/10.1186\/s13046-025-03537-x.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"3938_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12429-w","volume":"24","author":"L Thorel","year":"2024","unstructured":"Thorel L, Divoux J, Lequesne J, Babin G, Morice PM, Florent R, et al. The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers. BMC Cancer. 2024;24:701. https:\/\/doi.org\/10.1186\/s12885-024-12429-w.","journal-title":"BMC Cancer"},{"key":"3938_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10495-006-0625-4","volume":"12","author":"F Delom","year":"2007","unstructured":"Delom F, Fessart D, Chevet E. Regulation of calnexin sub-cellular localization modulates endoplasmic reticulum stress-induced apoptosis in MCF-7 cells. Apoptosis Int J Program Cell Death. 2007;12:293\u2013305. https:\/\/doi.org\/10.1007\/s10495-006-0625-4.","journal-title":"Apoptosis Int J Program Cell Death"},{"key":"3938_CR35","doi-asserted-by":"publisher","first-page":"e99269.","DOI":"10.1371\/journal.pone.0099269","volume":"9","author":"KW Kohn","year":"2014","unstructured":"Kohn KW, Zeeberg BM, Reinhold WC, Pommier Y. Gene expression correlations in human cancer cell lines define molecular interaction networks for epithelial phenotype. PLoS One. 2014;9:e99269. https:\/\/doi.org\/10.1371\/journal.pone.0099269.","journal-title":"PLoS One"},{"key":"3938_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbrc.2005.12.149","volume":"341","author":"F Delom","year":"2006","unstructured":"Delom F, Chevet E. In vitro mapping of calnexin interaction with ribosomes. Biochem Biophys Res Commun. 2006;341:39\u201344. https:\/\/doi.org\/10.1016\/j.bbrc.2005.12.149.","journal-title":"Biochem Biophys Res Commun"},{"key":"3938_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11:R25. https:\/\/doi.org\/10.1186\/gb-2010-11-3-r25.","journal-title":"Genome Biol"},{"key":"3938_CR38","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4933","volume":"14","author":"M Piecyk","year":"2024","unstructured":"Piecyk M, Fauvre J, Duret C, Chaveroux C, Ferraro-Peyret C. SUrface SEnsing of Translation (SUnSET), a method based on western blot assessing protein synthesis rates in vitro. Bio-Protoc. 2024;14:e4933. https:\/\/doi.org\/10.21769\/BioProtoc.4933.","journal-title":"Bio-Protoc"},{"key":"3938_CR39","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","volume":"166","author":"H Zhang","year":"2016","unstructured":"Zhang H, Liu T, Zhang Z, Payne SH, Zhang B, McDermott JE, et al. Integrated proteogenomic characterization of human high-grade serous ovarian cancer. Cell. 2016;166:755\u201365. https:\/\/doi.org\/10.1016\/j.cell.2016.05.069.","journal-title":"Cell"},{"key":"3938_CR40","doi-asserted-by":"publisher","first-page":"e16186.","DOI":"10.1371\/journal.pone.0016186","volume":"6","author":"R Strauss","year":"2011","unstructured":"Strauss R, Li ZY, Liu Y, Beyer I, Persson J, Sova P, et al. Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One. 2011;6:e16186. https:\/\/doi.org\/10.1371\/journal.pone.0016186.","journal-title":"PLoS One"},{"key":"3938_CR41","doi-asserted-by":"publisher","unstructured":"Fessart D, Mahouche I, Brouste V, Velasco V, Soubeyran I, Soubeyran P, et al. Anterior Gradient-2 (AGR2) is overexpressed in colon cancer and is a potential biomarker of microsatellite instability (MSI) tumors. bioRxiv. 2022;2021.09.07.459258. https:\/\/doi.org\/10.1101\/2021.09.07.459258","DOI":"10.1101\/2021.09.07.459258"},{"key":"3938_CR42","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.220068","volume":"12","author":"D Fessart","year":"2022","unstructured":"Fessart D, Villamor I, Chevet E, Delom F, Robert J. Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer. Open Biol. 2022;12:220068. https:\/\/doi.org\/10.1098\/rsob.220068.","journal-title":"Open Biol"},{"key":"3938_CR43","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1136\/gutjnl-2022-328739","volume":"72","author":"E Chevet","year":"2022","unstructured":"Chevet E, Bassal F, Beq S, Bonhomme B, Boisteau E, Calloch J, et al. AGR2 protein expression in colorectal tumour epithelial compartment. Gut. 2022;72:2385\u20136. https:\/\/doi.org\/10.1136\/gutjnl-2022-328739.","journal-title":"Gut"},{"key":"3938_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2586","volume":"12","author":"KE Vanderlaag","year":"2010","unstructured":"Vanderlaag KE, Hudak S, Bald L, Fayadat-Dilman L, Sathe M, Grein J, et al. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin. Breast Cancer Res BCR. 2010;12:R32. https:\/\/doi.org\/10.1186\/bcr2586.","journal-title":"Breast Cancer Res BCR"},{"key":"3938_CR45","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/pros.21273","volume":"71","author":"H Bu","year":"2011","unstructured":"Bu H, Bormann S, Sch\u00e4fer G, Horninger W, Massoner P, Neeb A, et al. The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection. The Prostate. 2011;71:575\u201387. https:\/\/doi.org\/10.1002\/pros.21273.","journal-title":"The Prostate"},{"key":"3938_CR46","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.2147\/CMAR.S304869","volume":"13","author":"J He","year":"2021","unstructured":"He J, Fu Y, Hu J, Chen J, Lou G. Hypomethylation-mediated AGR2 overexpression facilitates cell proliferation, migration, and invasion of lung adenocarcinoma. Cancer Manag Res. 2021;13:5177\u201385. https:\/\/doi.org\/10.2147\/CMAR.S304869.","journal-title":"Cancer Manag Res"},{"key":"3938_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28175","volume":"10","author":"C Zheng","year":"2024","unstructured":"Zheng C, Mao Y, Ye J, Zhang M, Chen Y. Function and mechanism of exogenous AGR2 in colorectal cancer cells. Heliyon. 2024;10:e28175. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28175.","journal-title":"Heliyon"},{"key":"3938_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101927","volume":"6","author":"H Li","year":"2025","unstructured":"Li H, Zhang Z, Shi Z, Zhou S, Nie S, Yu Y, et al. Disrupting AGR2\/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. Cell Rep Med. 2025;6:101927. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101927.","journal-title":"Cell Rep Med"},{"key":"3938_CR49","doi-asserted-by":"publisher","first-page":"e012710.","DOI":"10.1136\/jitc-2025-012710","volume":"13","author":"Y Yao","year":"2025","unstructured":"Yao Y, Luo Y, Wang Z, Yin E, Liu C, Zheng S, et al. Tumor-secreted AGR2 induces dendritic cell dysfunction and impairs immunotherapy efficacy in LKB1-deficient cancer. J Immunother Cancer. 2025;13:e012710. https:\/\/doi.org\/10.1136\/jitc-2025-012710.","journal-title":"J Immunother Cancer"},{"key":"3938_CR50","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1016\/j.febslet.2015.09.021","volume":"589","author":"C Amaya","year":"2015","unstructured":"Amaya C, Fader CM, Colombo MI. Autophagy and proteins involved in vesicular trafficking. FEBS Lett. 2015;589:3343\u201353. https:\/\/doi.org\/10.1016\/j.febslet.2015.09.021.","journal-title":"FEBS Lett"},{"key":"3938_CR51","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/cdd.2013.187","volume":"21","author":"X Ao","year":"2014","unstructured":"Ao X, Zou L, Wu Y. Regulation of autophagy by the Rab GTPase network. Cell Death Differ. 2014;21:348\u201358. https:\/\/doi.org\/10.1038\/cdd.2013.187.","journal-title":"Cell Death Differ"},{"key":"3938_CR52","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/tra.12283","volume":"16","author":"L Wartosch","year":"2015","unstructured":"Wartosch L, G\u00fcnesdogan U, Graham SC, Luzio JP. Recruitment of VPS33A to HOPS by VPS16 is required for lysosome fusion with endosomes and autophagosomes. Traffic Cph Den. 2015;16:727\u201342. https:\/\/doi.org\/10.1111\/tra.12283.","journal-title":"Traffic Cph Den"},{"key":"3938_CR53","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1038\/s41418-021-00809-9","volume":"28","author":"XS Rao","year":"2021","unstructured":"Rao XS, Cong XX, Gao XK, Shi YP, Shi LJ, Wang JF, et al. AMPK-mediated phosphorylation enhances the auto-inhibition of TBC1D17 to promote Rab5-dependent glucose uptake. Cell Death Differ. 2021;28:3214\u201334. https:\/\/doi.org\/10.1038\/s41418-021-00809-9.","journal-title":"Cell Death Differ"},{"key":"3938_CR54","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.molcel.2012.04.007","volume":"46","author":"YM Kim","year":"2012","unstructured":"Kim YM, Stone M, Hwang TH, Kim YG, Dunlevy JR, Griffin TJ, et al. SH3BP4 is a negative regulator of amino acid-Rag GTPase-mTORC1 signaling. Mol Cell. 2012;46:833\u201346. https:\/\/doi.org\/10.1016\/j.molcel.2012.04.007.","journal-title":"Mol Cell"},{"key":"3938_CR55","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1083\/jcb.200712051","volume":"181","author":"G Juh\u00e1sz","year":"2008","unstructured":"Juh\u00e1sz G, Hill JH, Yan Y, Sass M, Baehrecke EH, Backer JM, et al. The class III PI(3)K Vps34 promotes autophagy and endocytosis but not TOR signaling in Drosophila. J Cell Biol. 2008;181:655\u201366. https:\/\/doi.org\/10.1083\/jcb.200712051.","journal-title":"J Cell Biol"},{"key":"3938_CR56","doi-asserted-by":"publisher","first-page":"10964","DOI":"10.3390\/ijms222010964","volume":"22","author":"CA Chu","year":"2021","unstructured":"Chu CA, Wang YW, Chen YL, Chen HW, Chuang JJ, Chang HY, et al. The role of Phosphatidylinositol 3-Kinase catalytic subunit type 3 in the pathogenesis of human cancer. Int J Mol Sci. 2021;22:10964 https:\/\/doi.org\/10.3390\/ijms222010964.","journal-title":"Int J Mol Sci"},{"key":"3938_CR57","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1083\/jcb.146.4.765","volume":"146","author":"RJ Advani","year":"1999","unstructured":"Advani RJ, Yang B, Prekeris R, Lee KC, Klumperman J, Scheller RH. VAMP-7 mediates vesicular transport from endosomes to lysosomes. J Cell Biol. 1999;146:765\u201376. https:\/\/doi.org\/10.1083\/jcb.146.4.765.","journal-title":"J Cell Biol"},{"key":"3938_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08263-y","volume":"16","author":"Z Jian","year":"2025","unstructured":"Jian Z, Song J, Lu L, Pan T, Zhang H, Zhang Q, et al. AGR2 suppresses ferroptosis via the p53\/FPN1 regulatory axis and drives therapeutic vulnerabilities in pancreatic cancer. Cell Death Dis. 2025;16:877. https:\/\/doi.org\/10.1038\/s41419-025-08263-y.","journal-title":"Cell Death Dis"},{"key":"3938_CR59","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.trecan.2016.03.007","volume":"2","author":"H Urra","year":"2016","unstructured":"Urra H, Dufey E, Avril T, Chevet E, Hetz C. Endoplasmic Reticulum Stress and the Hallmarks of Cancer. Trends Cancer. 2016;2:252\u201362. https:\/\/doi.org\/10.1016\/j.trecan.2016.03.007.","journal-title":"Trends Cancer"},{"key":"3938_CR60","doi-asserted-by":"publisher","first-page":"C40","DOI":"10.1152\/ajpcell.00532.2018","volume":"318","author":"F Delom","year":"2020","unstructured":"Delom F, Mohtar MA, Hupp T, Fessart D. The anterior gradient-2 interactome. Am J Physiol Cell Physiol. 2020;318:C40\u20137. https:\/\/doi.org\/10.1152\/ajpcell.00532.2018.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3938_CR61","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1021\/acs.jproteome.7b00191","volume":"16","author":"A Naba","year":"2017","unstructured":"Naba A, Pearce OMT, Del Rosario A, Ma D, Ding H, Rajeeve V, et al. Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. J Proteome Res. 2017;16:3083\u201391. https:\/\/doi.org\/10.1021\/acs.jproteome.7b00191.","journal-title":"J Proteome Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03938-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03938-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03938-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:09:51Z","timestamp":1790168991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03938-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":61,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2026,10,20]]}},"alternative-id":["3938"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03938-y","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EC is a founding member of Thabor Therapeutics and of Exa Noma therapeutics, SB and MG are employees of Thabor Therapeutics, all the other authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods involving human-derived samples were performed in accordance with the relevant guidelines and regulations. The collection and use of patient-derived tumour organoids provided by our collaborators at the ORGAPRED Core Facility, Caen, were approved by the Biological Resources Centre \u201cCRB OvaRessources\u201d under approval\/reference number NF S 96-900. Informed consent was obtained from all participants included in this cohort. Separately, the collection and use of tumour sections from the local epithelial ovarian cancer cohort at Institut Bergoni\u00e9, Bordeaux, were approved by the Biological Resources Centre \u201cCRB Bergoni\u00e9 Institute\u201d under approval\/reference number BB-0033-00070. Informed consent was obtained from all participants included in this cohort.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}